← Back to headlines
Nomura Retains 'Buy' Rating for Alkem Laboratories Despite Earnings Miss
Nomura has maintained its 'Buy' rating for Alkem Laboratories, even after the company reported an earnings miss for the first quarter of fiscal year 2027.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
